Press Releases Year None2020201920182017 Atreca Announces Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting October 14, 2020 PDF Version READ MORE Atreca to Present at Two Upcoming Virtual Investor Conferences September 3, 2020 PDF Version READ MORE Atreca Reports Second Quarter 2020 Financial Results and Recent Corporate Developments August 12, 2020 PDF Version READ MORE Atreca to Present at Two Upcoming Virtual Healthcare Conferences August 5, 2020 PDF Version READ MORE Atreca, Inc. Announces Pricing of Underwritten Public Offering of Common Stock July 16, 2020 PDF Version READ MORE Atreca, Inc. Announces Proposed Underwritten Public Offering of Class A Common Stock July 15, 2020 PDF Version READ MORE Atreca and Xencor Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies July 8, 2020 PDF Version READ MORE Atreca Announces Webinar to Present ATRC-101 Preclinical Data Update on Monday, June 15, 2020 June 11, 2020 PDF Version READ MORE Atreca Announces Appointment of Kristine M. Ball to its Board of Directors May 21, 2020 PDF Version READ MORE Atreca Reports First Quarter 2020 Financial Results and Recent Corporate Developments May 14, 2020 PDF Version READ MORE Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 18
